Cite
Hypothesis: Fever control, a niche for alpha-2 agonists in the setting of septic shock and severe acute respiratory distress syndrome?
MLA
Petitjeans, F., et al. “Hypothesis: Fever Control, a Niche for Alpha-2 Agonists in the Setting of Septic Shock and Severe Acute Respiratory Distress Syndrome?” Temperature, vol. 5, no. 3, July 2018, pp. 224–56. EBSCOhost, https://doi.org/10.1080/23328940.2018.1453771.
APA
Petitjeans, F., Leroy, S., Pichot, C., Geloen, A., Ghignone, M., & Quintin, L. (2018). Hypothesis: Fever control, a niche for alpha-2 agonists in the setting of septic shock and severe acute respiratory distress syndrome? Temperature, 5(3), 224–256. https://doi.org/10.1080/23328940.2018.1453771
Chicago
Petitjeans, F., S. Leroy, C. Pichot, A. Geloen, M. Ghignone, and L. Quintin. 2018. “Hypothesis: Fever Control, a Niche for Alpha-2 Agonists in the Setting of Septic Shock and Severe Acute Respiratory Distress Syndrome?” Temperature 5 (3): 224–56. doi:10.1080/23328940.2018.1453771.